Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin Effect on Gut Microbiota in Newly Diagnosed Type 2 Diabetes
NCT02900417Unknown
- Sponsor
- The Second Affiliated Hospital of Soochow University
- Start
- Sep 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by The Second Affiliated Hospital of Soochow University. Primary endpoint: Changes of the composition of gut microbiota at 12 weeks. Status: unknown.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02900417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02900417.